Of note, the LKB1-AMPK pathway is the upstream negative regulator of mTOR signaling, and SIRT3 can active LKB1-AMPK signaling to inhibit mTOR regulated protein synthesis, which inhibits cardiac hypertrophy 125. Here, MTOR is linked to cardiac hypertrophy.